About University of Nebraska Medical Center, Department of Psychiatry
"The psychiatry staff at Nebraska Medicine provide diagnostic evaluations, second opinions, and treatment for a wide array of mental health problems regardless of your age. We treat everything from adjustment reactions to severe and persistent mental illness, reproductive psychiatry, and more."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
University of Nebraska
3
Shire
2
Clinical Trials at University of Nebraska Medical Center, Department of Psychiatry
During the past decade, University of Nebraska Medical Center, Department of Psychiatry conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Dose Response Relationship of Oxytocin on Irritability in Youths
2022-02-18
2023-08-01
Recruiting
80
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nebraska Medical Center, Department of Psychiatry"
#1 collaborator was "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Nebraska Medical Center, Department of Psychiatry
According to Clinical.Site data, the most researched conditions in "University of Nebraska Medical Center, Department of Psychiatry" are
"ADHD" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials), "Disruptive Behavior Disorders" (1 trials) and "Irritable Mood" (1 trials). Many other conditions were trialed in "University of Nebraska Medical Center, Department of Psychiatry" in a lesser frequency.
Clinical Trials Intervention Types at University of Nebraska Medical Center, Department of Psychiatry
Most popular intervention types in "University of Nebraska Medical Center, Department of Psychiatry" are "Drug" (4 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Atomoxetine Hydrochloride" (1 trials), "Extended-release Guanfacine Hydrochloride" (1 trials), "Lisdexamfetamine dimesylate" (1 trials) and "Methylphenidate Hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Nebraska Medical Center, Department of Psychiatry
The vast majority of trials in "University of Nebraska Medical Center, Department of Psychiatry" are
5 trials for "All" genders.
Clinical Trials Status at University of Nebraska Medical Center, Department of Psychiatry
Currently, there are NaN active trials in "University of Nebraska Medical Center, Department of Psychiatry".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in University of Nebraska Medical Center, Department of Psychiatry,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Nebraska Medical Center, Department of Psychiatry, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".